|
CAS No:221227-05-0
10: PN:WO2007093839 SEQID: 16 claimed protein 3: PN: US20040132667 SEQID: 3 claimedprotein N-Palmitoylrigin
|
|
CAS No:2484708-86-1
2484708-86-1 Acetyl Hexapeptide-8 Argireline
|
|
CAS No:117592-45-7
alpha-Casozepine 117592-45-7 Casein hydrolysate
|
|
CAS No:32607-79-7
Glutathione trisulfide GSSSG Neuroprotective agent; Anti-inflammatory
|
|
CAS No:2239-67-0
L-Proline,1-(1-glycyl-L-prolyl)-4-hydroxy- (6CI) L-Proline,1-(1-glycyl-L-prolyl)-4-hydroxy-, trans- Proline, 1-(1-glycyl-L-prolyl)-4-hydroxy-(7CI)
|
|
CAS No:2883634-40-8
Eloralintide Amylin Receptor Agonist LY3841136
|
|
CAS No:127199-14-8
(1S,2S)-2-Fluorocyclopropanecarboxylicacid (1S,2S)-(+)-CIS-2-FLUOROCYCLOPROPANECARBOXYLIC ACID (1S,2S)-2-fluorocyclopropane-1-carboxylic acid
|
|
CAS No:920014-72-8
920014-72-8 RM-493, BIM-22493, MC4R agonist Setmelanotide
|
|
CAS No:175175-23-2
Glu-Asp-Arg EDR Peptide 175175-23-2
|
|
CAS No:911813-90-6
Palmitoyl Dipeptide-7 911813-90-6 Cosmetic Peptide
|
|
CAS No:64577-63-5
L-Valine,N-(trifluoroacetyl)-L-valyl-L-tyrosyl- (9CI) L-Valine,N-[N-[N-(trifluoroacetyl)-L-valyl]-L-tyrosyl]- 64577-63-5
|
|
CAS No:49557-75-7
L-Lysine,N2-(N-glycyl-L-histidyl)- Glycyl-L-histidyl-L-lysine Growth-modulating peptide (human)
|
|
CAS No:623172-55-4
Palmitoyl Tripeptide-5 623172-55-4 Syn-Coll
|
|
CAS No:147732-56-7
L-Lysine,N2-[N-[N-(1-oxohexadecyl)glycyl]-L-histidyl]- 11: PN: WO2007093839 SEQID: 17claimed protein Biopeptide CL
|
|
CAS No:221227-05-0
10: PN:WO2007093839 SEQID: 16 claimed protein 3: PN: US20040132667 SEQID: 3 claimedprotein N-Palmitoylrigin
|
|
CAS No:214047-00-4
Matrixyl Palmitoyl Pentapeptide-4 214047-00-4
|
|
CAS No:2828433-36-7
Acetyl Hexapeptide-1 2828433-36-7 Cosmetic Peptide
|
|
CAS No:959610-30-1
N2-(1-Oxotetradecyl)-L-lysyl-L-leucyl-L-alanyl-L-lysyl-L-lysinamide Myristoyl Pentapeptide-17 sympeptide226
|
|
CAS No:820959-17-9
820959-17-9 Acetyl Tetrapeptide-5 Eyeseryl
|
|
CAS No:1392416-25-9
Myristoyl Pentapeptide-4 1392416-25-9 Cosmetic Peptide
|
